(Q81554197)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Timely levodopa (LD) administration prolongs survival in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

A H Rajput

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R J Uitti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A H Rajput

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

K P Offord

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

number of pages

7

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

159-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

Parkinsonism: onset, progression, and mortality

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Levodopa in Parkinson disease: a long-term appraisal of mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

The changing patterns of death rates in parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Long-term follow-up of early dopa treatment in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

To treat early or to treat late?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Does levodopa therapy delay death in Parkinson's disease? A review of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Neurological disorders and services in Saskatchewan--a report based on provincial health care records.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Toward a definition of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Two decades of increasing mortality from Parkinson's disease among the US elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Epidemiology of parkinsonism: Incidence, classification, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Effect of age at onset on progression and mortality in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Mortality of patients with parkinson's disease treated with levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Pulmonary embolism: an under-recognized yet frequent cause of death in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Mortality associated with early and late levodopa therapy initiation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Multi-center study of Parkinson mortality with early versus later dopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

Clinical course of patients with idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2897%2900030-8

7 January 2021

10.1016/S1353-8020(97)00030-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18591070%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference